Recruitment successfully completed in Dimerix' ACTION3 Phase 3 clinical trial [1], which has recruited and dosed its target 286 th adult patient The ACTION3 Phase 3 trial explores the efficacy and ...

MELBOURNE, Australia, Dec. 15, 2025 /PRNewswire/ -- Dimerix Limited (ASX: DXB), a biopharmaceutical company with a Phase 3 clinical asset in kidney disease, today announces that the ACTION3 Phase 3 ...

(Alliance News) - PureTech Health PLC on Monday said its idiopathic pulmonary fibrosis drug candidate deupirfenidone has cleared a key regulatory milestone, with the US Food & Drug Administration ...

If successful, a single phase 3 trial, combined with the totality of prior data, could support regulatory approval via a streamlined 505(b)(2) pathway. The US Food and Drug Administration (FDA) has ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Daniel Medved, 33, is a single dad of three who works full time at a tech company. Strict work-life boundaries, a flexible job, and a good support system help him stay balanced. Medved is among a ...

aTyr Pharma is a small-cap biotech focused on Efzofitimod for interstitial lung disease (ILD), a group of lung-scarring diseases. In 2021, the company completed a phase 1b/2a trial in pulmonary ...

The biggest stories of the day delivered to your inbox.

Obefazimod’s strong Phase 3 induction data positions Abivax as a leading UC contender, with a novel mechanism and favorable safety profile. The ABTECT program’s robust design and inclusion of ...

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has completed enrollment in SHASTA-3, SHASTA-4, and MUIR-3, the company’s global Phase 3 ...

Singlehood isn’t all good or all bad. It’s a complex experience in a society that puts romantic relationships on a pedestal. Despite this, here’s how some people thrive in it. Are you good at being ...

Hydroxyurea vs. hypomethylating vs. other agents in chronic myelomonocytic leukemia: A retrospective inspection of treatment strategies among 457 Mayo Clinic patients. This is an ASCO Meeting Abstract ...